Home > Strategic alliances
Strategic Alliances
Anaxomics wishes to stablish long-term strategic alliances with the customers in order to:
Identify new drug targets
By thoroughly exploring the patophysiological map of a given disease, we help our clients identify new proteins than can become targets for the developing of new compounds.
New targets for immflamation identified in the patophysiological patway.
Identify new Biomarkers
Following the same philosophy, we help our clients to identify new targets that are closely related with the patology, and that at the same time, can be proteins easily identifiable in body samples.
Identify mechanisms of action
FDA and EMEA are emphasizing the importance of understanding the molecular and physiological basis of therapies by using the new tools of Predictive Medicine. We will be providing you the cutting-edge most-updated Predictive Medicine tools to explain the best model to explain the mechanism of action of your compound.
